83 related articles for article (PubMed ID: 15256485)
1. Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-alpha-induced apoptosis in human cancer cells.
Zhang S; Lin ZN; Yang CF; Shi X; Ong CN; Shen HM
Carcinogenesis; 2004 Nov; 25(11):2191-9. PubMed ID: 15256485
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha mediates activation of NF-κB and JNK signaling cascades in retinal ganglion cells and astrocytes in opposite ways.
Dvoriantchikova G; Ivanov D
Eur J Neurosci; 2014 Oct; 40(8):3171-8. PubMed ID: 25160799
[TBL] [Abstract][Full Text] [Related]
3. Sesquiterpene Lactones Containing an α-Methylene-γ-Lactone Moiety Selectively Down-Regulate the Expression of Tumor Necrosis Factor Receptor 1 by Promoting Its Ectodomain Shedding in Human Lung Adenocarcinoma A549 Cells.
Vu QV; Sayama S; Ando M; Kataoka T
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675685
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles for JNK1 and JNK3 during TNF-alpha- or etoposide-induced apoptosis in HeLa cells.
Ham YM; Lim JH; Lee SK
Mol Cells; 2009 Dec; 28(6):509-13. PubMed ID: 20552320
[TBL] [Abstract][Full Text] [Related]
5. Fructose protects murine hepatocytes from tumor necrosis factor-induced apoptosis by modulating JNK signaling.
Speicher T; Köhler UA; Choukèr A; Werner S; Weiland T; Wendel A
J Biol Chem; 2012 Jan; 287(3):1837-46. PubMed ID: 22086922
[TBL] [Abstract][Full Text] [Related]
6. The hepatitis B virus pre-core protein p22 suppresses TNFα-induced apoptosis by regulating the NF-κB pathway.
Diao Z; Luo H; Li Y; Ma Z; Tang F; Cao B; Feng Y; Mo Z; Gao H
Am J Transl Res; 2023; 15(8):5184-5196. PubMed ID: 37692946
[TBL] [Abstract][Full Text] [Related]
7. Parthenolide induces ROS-dependent cell death in human gastric cancer cell.
Han D; Zhu W; Chen Y; Wang H
Adv Clin Exp Med; 2024 Jan; ():. PubMed ID: 38197565
[TBL] [Abstract][Full Text] [Related]
8. Novel formulation of parthenolide-loaded liposome coated with chitosan and evaluation of its potential anticancer effects in vitro.
Ensaf PK; Goodarzi MT; Tabrizi MH; Neamati A; Hosseinyzadeh SS
Mol Biol Rep; 2024 Feb; 51(1):369. PubMed ID: 38411765
[TBL] [Abstract][Full Text] [Related]
9. Molecular changes associated with increased TNF-α-induced apoptotis in naïve (T
Gupta S; Su H; Agrawal S; Gollapudi S
Immun Ageing; 2018; 15():2. PubMed ID: 29387134
[TBL] [Abstract][Full Text] [Related]
10. The Natural Product Parthenolide Inhibits Both Angiogenesis and Invasiveness and Improves Gemcitabine Resistance by Suppressing Nuclear Factor κB Activation in Pancreatic Cancer Cell Lines.
Denda Y; Matsuo Y; Sugita S; Eguchi Y; Nonoyama K; Murase H; Kato T; Imafuji H; Saito K; Morimoto M; Ogawa R; Takahashi H; Mitsui A; Kimura M; Takiguchi S
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474833
[TBL] [Abstract][Full Text] [Related]
11. TOP1 inhibition induces bifurcated JNK/MYC signaling that dictates cancer cell sensitivity.
Liu Q; Chung S; Murata MM; Han B; Gao B; Zhang M; Lee TY; Chirshev E; Unternaehrer J; Tanaka H; Giuliano AE; Cui Y; Cui X
Int J Biol Sci; 2022; 18(10):4203-4218. PubMed ID: 35844787
[No Abstract] [Full Text] [Related]
12. Design, Synthesis, and Antileukemic Evaluation of a Novel Mikanolide Derivative Through the Ras/Raf/MEK/ERK Pathway.
Rao Q; Xie K; Varier KM; Huang L; Song J; Yang J; Qiu J; Huang Y; Li Y; Gajendran B; Li Y; Liu S
Front Pharmacol; 2022; 13():809551. PubMed ID: 35721186
[TBL] [Abstract][Full Text] [Related]
13. The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy.
An T; Yin H; Lu Y; Liu F
Drug Des Devel Ther; 2022; 16():1255-1272. PubMed ID: 35517982
[TBL] [Abstract][Full Text] [Related]
14. Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties.
Carlisi D; Lauricella M; D'Anneo A; De Blasio A; Celesia A; Pratelli G; Notaro A; Calvaruso G; Giuliano M; Emanuele S
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203723
[TBL] [Abstract][Full Text] [Related]
15. Combination of Wogonin and Artesunate Exhibits Synergistic anti-Hepatocellular Carcinoma Effect by Increasing DNA-Damage-Inducible Alpha, Tumor Necrosis Factor α and Tumor Necrosis Factor Receptor-Associated Factor 3-mediated Apoptosis.
Chen M; Wu HL; Wong TS; Chen B; Gong RH; Wong HLX; Xiao H; Bian Z; Kwan HY
Front Pharmacol; 2021; 12():657080. PubMed ID: 34025421
[TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor-α (TNF-α) enhances dietary carcinogen-induced DNA damage in colorectal cancer epithelial cells through activation of JNK signaling pathway.
Alotaibi AG; Li JV; Gooderham NJ
Toxicology; 2021 Jun; 457():152806. PubMed ID: 33961948
[TBL] [Abstract][Full Text] [Related]
17. Roles of Inflammasomes in Epstein-Barr Virus-Associated Nasopharyngeal Cancer.
Looi CK; Hii LW; Chung FF; Mai CW; Lim WM; Leong CO
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33918087
[TBL] [Abstract][Full Text] [Related]
18. Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies.
Sztiller-Sikorska M; Czyz M
Pharmaceuticals (Basel); 2020 Aug; 13(8):. PubMed ID: 32823992
[TBL] [Abstract][Full Text] [Related]
19. Inflammasome inhibitors: promising therapeutic approaches against cancer.
Xu S; Li X; Liu Y; Xia Y; Chang R; Zhang C
J Hematol Oncol; 2019 Jun; 12(1):64. PubMed ID: 31242947
[TBL] [Abstract][Full Text] [Related]
20. BRCA2 deficiency instigates cGAS-mediated inflammatory signaling and confers sensitivity to tumor necrosis factor-alpha-mediated cytotoxicity.
Heijink AM; Talens F; Jae LT; van Gijn SE; Fehrmann RSN; Brummelkamp TR; van Vugt MATM
Nat Commun; 2019 Jan; 10(1):100. PubMed ID: 30626869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
